READ. SCROLL. LISTEN.

Original briefings. Zero spin.

Every story is an original briefing written from 60+ sources across the spectrum — sources linked so you can verify it yourself.

← Back to headlines

Trump Administration Will Let Medicare Part D Subsidy Expire After 2026, WSJ Reports

Trump Administration Will Let Medicare Part D Subsidy Expire After 2026, WSJ Reports
The Wall Street Journal reports the Trump administration won't renew a roughly $3.6 billion subsidy program that has helped hold down Medicare Part D premiums. An administration official says the subsidy was letting insurers pad premiums on the government's dime. Seniors on fixed incomes will be watching what their plans charge starting in 2027.

The Trump administration plans to let a Medicare Part D premium subsidy expire at the end of 2026, according to the Wall Street Journal, which cited government officials familiar with the decision. Reuters confirmed the Journal's reporting on Tuesday, July 28. The program in question has provided insurers roughly $3.6 billion this year to help cushion premium increases for Medicare's prescription drug plans, according to the Journal's reporting as relayed by Reuters. Without it, insurers absorb more of their own cost increases starting next year, and some of that cost is expected to land on beneficiaries. Medicare Part D covers prescription drugs for millions of seniors through private insurance plans. Nearly 25 million people were enrolled in standalone Part D plans in 2026, according to data from KFF, the health policy research group.

What the administration is saying

An administration official told the Journal the subsidy gave insurers an incentive to raise premiums in the first place, because the government was picking up much of the added cost. Subsidize insurers to hold premiums down, and you may just be paying them to raise sticker prices while taxpayers cover the difference. The same official said other cost-control measures for Part D remain in place, and that the subsidy specifically is no longer necessary. According to that official, roughly a quarter of Part D beneficiaries will see premiums stay flat or drop next year, and about 30% will see increases of less than $10 a month. That leaves a significant chunk of beneficiaries, by the administration's own numbers, facing increases of $10 a month or more. Neither the Journal's reporting nor Reuters' account specifies exactly how large those increases could run for the remaining enrollees, and CMS, which administers Part D, hasn't released a detailed accounting of expected premium changes plan-by-plan.

The Democratic

response The Democratic National Committee, in a statement from Rapid Response Director Kendall Witmer, framed the move as part of a broader pattern, tying it to the nearly $1 trillion in Medicaid cuts Republicans passed and the expiration of enhanced Affordable Care Act tax credits, which the DNC says has already driven ACA marketplace premiums up an average of 58%. Witmer's statement put the number of Americans affected by the Part D subsidy change at more than 11 million, framing it as Trump and Republicans making healthcare "unaffordable for Americans, especially for seniors." 6 billion) and total Part D enrollment (nearly 25 million) but don't break out a specific number of people who will see premium increases. The DNC's broader point, that Republicans allowed enhanced ACA subsidies to lapse and passed major Medicaid cuts through the reconciliation bill, is separately documented and not really in dispute. Whether that amounts to a deliberate strategy to gut safety-net programs, as the DNC statement asserts, is the DNC's political characterization, not an established fact.

The administration's stronger argument, stated fairly

The administration's underlying logic deserves a fair hearing. If a subsidy is structured so the government eats most of the cost of a premium hike, insurers have less reason to hold the line on prices. That's a real economic argument, not a talking point invented for this story, and it's one Republicans have made about health insurance subsidies generally. If the subsidy really was inflating the baseline premiums insurers set, ending it could in theory restore some pressure on insurers to compete on price rather than pad costs knowing Washington will cover the gap. Theory and outcome aren't the same thing. The administration's own numbers say a quarter of beneficiaries see no change, but that also means three-quarters will see some kind of increase, with 30% facing under $10 a month and an unspecified remainder facing more. For someone on a fixed Social Security check, even a $15 or $20 monthly jump on top of other rising costs is a real bite, and the sources here don't give a ceiling on how high those increases could go for the higher-cost tiers.

What's unresolved

The final 2027 premium numbers, and how many beneficiaries land in the higher-increase bracket rather than the sub-$10 group, won't be clear until CMS publishes its annual plan data later this year. Insurers themselves have not yet issued public statements on how they'll adjust premiums once the subsidy disappears.

Sources used for this briefing

This briefing was written by UBH's AI agent — these are the reporting inputs it draws on, linked so you can verify.

left
The GuardianTrump administration reportedly plans to end Medicare subsidy that tempers drug costs for seniors – live
unknown
wmbdradioTrump administration plans to end Medicare drug plan subsidy, WSJ reports
unknown
democratsBREAKING: Trump Administration Raising Medicare Premiums for More Than 11 Million Americans by Eliminating Medicare Part D Subsidies